NO20011961L - PRV-1-genet og anvendelsen av dette - Google Patents

PRV-1-genet og anvendelsen av dette

Info

Publication number
NO20011961L
NO20011961L NO20011961A NO20011961A NO20011961L NO 20011961 L NO20011961 L NO 20011961L NO 20011961 A NO20011961 A NO 20011961A NO 20011961 A NO20011961 A NO 20011961A NO 20011961 L NO20011961 L NO 20011961L
Authority
NO
Norway
Prior art keywords
gene
prv
encodes
detecting
well
Prior art date
Application number
NO20011961A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011961D0 (no
Inventor
Heike Pahl
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Publication of NO20011961D0 publication Critical patent/NO20011961D0/no
Publication of NO20011961L publication Critical patent/NO20011961L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20011961A 1998-10-23 2001-04-20 PRV-1-genet og anvendelsen av dette NO20011961L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19849044A DE19849044A1 (de) 1998-10-23 1998-10-23 Das Gen PRV-1 und dessen Verwendung
PCT/EP1999/007238 WO2000024886A1 (de) 1998-10-23 1999-09-30 Das gen prv-1 und dessen verwendung

Publications (2)

Publication Number Publication Date
NO20011961D0 NO20011961D0 (no) 2001-04-20
NO20011961L true NO20011961L (no) 2001-06-21

Family

ID=7885492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011961A NO20011961L (no) 1998-10-23 2001-04-20 PRV-1-genet og anvendelsen av dette

Country Status (28)

Country Link
US (2) US6686153B1 (bg)
EP (1) EP1123392B1 (bg)
JP (1) JP2002528077A (bg)
KR (1) KR20010080883A (bg)
CN (1) CN1190491C (bg)
AT (1) ATE348109T1 (bg)
AU (1) AU771772B2 (bg)
BG (1) BG105460A (bg)
BR (1) BR9915537A (bg)
CA (1) CA2349211A1 (bg)
CZ (1) CZ20011430A3 (bg)
DE (2) DE19849044A1 (bg)
EA (1) EA200100440A1 (bg)
EE (1) EE200100234A (bg)
HR (1) HRP20010294A2 (bg)
HU (1) HUP0104954A3 (bg)
IL (1) IL142664A0 (bg)
LT (1) LT4877B (bg)
LV (1) LV12722B (bg)
MX (1) MXPA01004035A (bg)
NO (1) NO20011961L (bg)
NZ (1) NZ510970A (bg)
PL (1) PL347413A1 (bg)
SI (1) SI20585A (bg)
SK (1) SK5402001A3 (bg)
WO (1) WO2000024886A1 (bg)
YU (1) YU29801A (bg)
ZA (1) ZA200103210B (bg)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1141285A2 (en) * 1998-12-16 2001-10-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE19947010A1 (de) * 1999-09-30 2001-04-05 Universitaetsklinikum Freiburg Das Gen PRV-1 und dessen Verwendung
CA2715080C (en) 2007-09-28 2021-09-28 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU746956B2 (en) * 1997-05-06 2002-05-09 Zymogenetics Inc. Novel tumor antigens

Also Published As

Publication number Publication date
HUP0104954A2 (hu) 2002-04-29
HUP0104954A3 (en) 2004-07-28
YU29801A (sh) 2005-07-19
HRP20010294A2 (en) 2002-06-30
IL142664A0 (en) 2002-03-10
DE19849044A1 (de) 2000-04-27
US20040259110A1 (en) 2004-12-23
EE200100234A (et) 2002-08-15
LV12722B (en) 2002-01-20
JP2002528077A (ja) 2002-09-03
EP1123392A1 (de) 2001-08-16
PL347413A1 (en) 2002-04-08
NO20011961D0 (no) 2001-04-20
SK5402001A3 (en) 2001-09-11
ZA200103210B (en) 2002-08-14
DE59914061D1 (de) 2007-01-25
BG105460A (bg) 2002-06-28
EP1123392B1 (de) 2006-12-13
SI20585A (sl) 2001-12-31
KR20010080883A (ko) 2001-08-25
AU771772B2 (en) 2004-04-01
CN1190491C (zh) 2005-02-23
BR9915537A (pt) 2001-11-13
CN1324403A (zh) 2001-11-28
AU6088399A (en) 2000-05-15
US6686153B1 (en) 2004-02-03
ATE348109T1 (de) 2007-01-15
LV12722A (lv) 2001-09-20
NZ510970A (en) 2003-06-30
LT2001055A (en) 2001-10-25
CA2349211A1 (en) 2000-05-04
WO2000024886A1 (de) 2000-05-04
LT4877B (lt) 2002-01-25
MXPA01004035A (es) 2003-03-10
CZ20011430A3 (cs) 2001-08-15
EA200100440A1 (ru) 2001-10-22

Similar Documents

Publication Publication Date Title
DK1196637T3 (da) Peptidacceptor-ligeringsmetoder
AU2003291962A1 (en) Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same
WO2001023575A3 (en) Wuschel (wus) gene homologs
ATE310090T1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
WO2001064835A8 (en) Novel nucleic acids and polypeptides
IL161769A0 (en) Anbtimicrobial polypeptides from pseudoplectania nigrella
DK0698105T3 (da) Nukleotidsekvenser til styring af ekspressionen af DNAsekvenser i en værtscelle
DK1383903T3 (da) Fremgangsmåder til fremstilling af askorbinsyre-intermediater i vært-celler
WO2001064834A8 (en) Novel nucleic acids and polypeptides
BRPI0418229A (pt) genes do ciclo celular e métodos corrrelatos de uso
DK0981631T3 (da) Polypeptider, som har aminopeptidase-aktivitet, og nukleinsyrer, som koder for samme
ATE450610T1 (de) Pflanzliche defensine
NO20011961L (no) PRV-1-genet og anvendelsen av dette
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
IT1275909B1 (it) Frammento di dna codificante d-amminoacido ossidasi
EA199801007A1 (ru) Способ биосинтеза, позволяющий получать кобаламины
WO2002083727A3 (de) Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
ATE361983T1 (de) Für eine phosphomevalonatkinase (pmk) kodierendes gen erg8 aus candida albicans
WO2002046378A3 (en) Alternative pol k nucleotide and amino acid sequence and methods for using
AU2001287860A1 (en) Transglutaminase gene products
DK1476582T3 (da) Nukleotidsekvens kodende for et TolC, som indeholder en heterolog aminosyresekvens
DK1794294T3 (da) Rekombinant carboxypeptidase B

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application